State Street Corp Belite Bio, Inc Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Belite Bio, Inc stock. As of the latest transaction made, State Street Corp holds 16,670 shares of BLTE stock, worth $761,485. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,670
Previous 17,557
5.05%
Holding current value
$761,485
Previous $803,000
20.42%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BLTE
# of Institutions
12Shares Held
58.1KCall Options Held
0Put Options Held
0-
Marshall Wace, LLP London, X010.6KShares$483,4770.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.7KShares$397,4160.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.7KShares$306,0560.0% of portfolio
-
Morgan Stanley New York, NY6.09KShares$278,1910.0% of portfolio
-
Cubist Systematic Strategies, LLC Stamford, CT4.79KShares$218,7150.0% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $1.14B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...